Takaji Wakita Selected Research

Takaji Wakita Research Topics

Disease

167	Infections 02/2024 - 04/2003
23	Hepatocellular Carcinoma (Hepatoma) 01/2023 - 11/2005
19	Virus Diseases (Viral Diseases) 03/2022 - 01/2007
15	Chronic Hepatitis C 12/2018 - 11/2005
13	COVID-19 01/2023 - 01/2020
13	Hepatitis B 01/2021 - 11/2013
8	Hepatitis 01/2021 - 09/2008
8	Hepatitis A (Hepatitis, Infectious) 12/2014 - 11/2005
7	Neoplasms (Cancer) 03/2021 - 08/2003
6	Liver Diseases (Liver Disease) 01/2018 - 07/2011
6	Massive Hepatic Necrosis 02/2015 - 03/2003
5	Fibrosis (Cirrhosis) 03/2021 - 02/2006
5	Chronic Hepatitis B 01/2021 - 09/2015
5	Chronic Hepatitis (Chronic Active Hepatitis) 01/2016 - 03/2003
3	Hepatitis C 01/2022 - 07/2011
3	Hepatitis E 01/2019 - 10/2010
3	Poliomyelitis (Polio) 03/2018 - 11/2011
3	Persistent Infection 01/2017 - 03/2014
2	Diarrhea 01/2023 - 04/2021
2	Carcinogenesis 01/2021 - 08/2003
2	Vesicular Stomatitis 03/2019 - 01/2013
2	Inflammation (Inflammations) 10/2018 - 07/2009
2	Viremia 07/2015 - 09/2008
2	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 02/2014 - 08/2013
2	Liver Cirrhosis (Hepatic Cirrhosis) 11/2013 - 04/2011

Drug/Important Bio-Agent (IBA)

43	Proteins (Proteins, Gene)FDA Link 02/2024 - 03/2003
32	Antiviral Agents (Antivirals)IBA 01/2023 - 06/2005
23	RNA (Ribonucleic Acid)IBA 12/2021 - 01/2007
22	InterferonsIBA 01/2021 - 11/2005
16	VaccinesIBA 01/2023 - 06/2005
15	AntibodiesIBA 01/2023 - 12/2007
14	sodium-bile acid cotransporterIBA 11/2021 - 02/2014
10	AntigensIBA 04/2021 - 01/2013
10	Ribavirin (Virazole)FDA LinkGeneric 01/2016 - 11/2005
8	Monoclonal AntibodiesIBA 01/2022 - 11/2005
8	Complementary DNA (cDNA)IBA 05/2014 - 11/2005
7	Viral RNAIBA 01/2020 - 04/2009
6	CytokinesIBA 12/2021 - 03/2010
6	Neutralizing AntibodiesIBA 10/2021 - 10/2008
6	Peptides (Polypeptides)IBA 01/2019 - 11/2015
6	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 04/2003
6	LipidsIBA 12/2018 - 04/2009
5	Small Interfering RNA (siRNA)IBA 01/2022 - 12/2007
5	Immunoglobulin G (IgG)IBA 10/2021 - 08/2013
5	MicroRNAs (MicroRNA)IBA 04/2021 - 03/2010
5	Circular DNAIBA 01/2021 - 09/2014
5	NucleosidesIBA 10/2019 - 03/2010
5	Immunoglobulin M (IgM)IBA 11/2018 - 09/2009
5	Messenger RNA (mRNA)IBA 10/2018 - 01/2007
4	Scavenger Receptors (Scavenger Receptor)IBA 02/2024 - 12/2007
4	Glycoproteins (Glycoprotein)IBA 11/2022 - 11/2005
4	Membrane Proteins (Integral Membrane Proteins)IBA 01/2021 - 07/2009
4	DiamondIBA 01/2021 - 01/2020
4	OccludinIBA 01/2021 - 05/2016
4	Amino Acids FDA Link 01/2021 - 01/2014
4	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2019 - 01/2014
3	P-selectin ligand proteinIBA 02/2024 - 07/2009
3	EnzymesIBA 12/2022 - 01/2015
3	LuciferasesIBA 01/2022 - 02/2010
3	CholesterolIBA 03/2021 - 06/2008
3	Drug CombinationsIBA 01/2021 - 01/2017
3	EpitopesIBA 01/2021 - 12/2007
3	Indicators and Reagents (Reagents)IBA 01/2017 - 03/2009
3	Alanine Transaminase (SGPT)IBA 01/2017 - 08/2003
3	CollagenIBA 01/2015 - 06/2010
3	Pyridinolcarbamate (P23)IBA 07/2010 - 03/2003
2	Nelfinavir (Viracept)FDA Link 01/2023 - 04/2021
2	Protein Isoforms (Isoforms)IBA 01/2023 - 10/2013
2	Hepatitis C AntibodiesIBA 01/2022 - 01/2018
2	Troglitazone (Rezulin)FDA Link 11/2021 - 01/2018
2	2,4-thiazolidinedione (thiazolidinedione)IBA 11/2021 - 01/2018
2	Virus ReceptorsIBA 11/2021 - 01/2015
2	OxysterolsIBA 03/2021 - 01/2014
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2021 - 01/2018
2	Coffee FDA Link 01/2019 - 01/2015
2	caffeic acidIBA 01/2019 - 01/2015
2	Viral ProteinsIBA 01/2019 - 01/2015
2	Vitamin D FDA LinkGeneric 12/2018 - 08/2016
2	LigandsIBA 01/2018 - 02/2014
2	entecavir FDA Link 01/2017 - 01/2017
2	Protease Inhibitors (Protease Inhibitor)IBA 01/2017 - 01/2013
2	VLDL LipoproteinsIBA 04/2016 - 10/2010
2	Apolipoproteins E (ApoE)IBA 01/2016 - 06/2011
2	Lipoproteins (Lipoprotein)IBA 01/2016 - 12/2007
2	Transaminases (Aminotransferases)IBA 01/2016 - 03/2014
2	Clathrin Heavy ChainsIBA 05/2015 - 12/2014
2	Claudin-1IBA 05/2015 - 12/2014
2	Serine Proteases (Serine Protease)IBA 02/2015 - 01/2009
2	Interferon Type IIBA 01/2015 - 12/2007
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2015 - 01/2009
2	AcidsIBA 01/2015 - 01/2012
2	bafilomycin A1IBA 12/2014 - 07/2006
2	ApolipoproteinsIBA 12/2014 - 10/2012
2	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 02/2014 - 08/2013
2	AlbuminsIBA 02/2014 - 06/2010
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2014 - 12/2012
2	Peptide Hydrolases (Proteases)FDA Link 11/2013 - 11/2010

Therapy/Procedure

21	Therapeutics 04/2021 - 11/2005
2	Liver Transplantation 01/2022 - 01/2018
2	Intravenous Injections 02/2014 - 04/2013